Tracy-Lynn E. Lockwood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tracy-Lynn E. Lockwood has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Marya Lieberman
Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, USA
5 shared publications - Alex Richard
Department of Chemistry and Biochemistry, College of Science, University of Notre Dame, South Bend, IN, 46556, United States
2 shared publications - Alec Helmke
Department of Chemistry & Biochemistry University of Notre Dame 251 Stepan Hall of Chemistry Notre Dame IN 46556
1 shared publication Alexandra Vervoordt
University of Notre Dame
1 shared publication- Alexandra Vervoordt
Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, USA
1 shared publication - Bradley Ray
RTI International, Research Triangle Park, USA
1 shared publication
Latest Publications
- 1 July 2021
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 224, 108722
Community overdose surveillance: Comparing substances collected from the death scene investigation to toxicology results
- 1 July 2021
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 224, 108722
Community overdose surveillance: Comparing substances collected from the death scene investigation to toxicology results
- Open Access
- 9 March 2021
- Published by Springer Nature in Harm Reduction Journal
- Vol. 18 (1) , 1-9
High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips
Background: The opioid epidemic has caused an increase in overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interferents. We tested whether these concentrated samples could cause false positive results on a FTS. Methods: 20 ng/mL Rapid Response FTS were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants [cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)] in concentrations from 20 to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection. Results: False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants. Conclusions: Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drugs and adulterants are in high concentrations, FTS can give a false positive result.
- 9 March 2021
- Published by Springer Nature in Harm Reduction Journal
- Vol. 18 (1) , 1-9
Open AccessHigh concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips
Background: The opioid epidemic has caused an increase in overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interferents. We tested whether these concentrated samples could cause false positive results on a FTS. Methods: 20 ng/mL Rapid Response FTS were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants [cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)] in concentrations from 20 to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection. Results: False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants. Conclusions: Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drugs and adulterants are in high concentrations, FTS can give a false positive result.
- Open Access
- 16 October 2020
- Published by Springer Nature in Research Square
High Concentrations of Illicit Stimulants and Cutting Agents Cause False Positives on Fentanyl Test Strips
Background:The opioid epidemic has caused an increase of overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interference. We tested whether these concentrated samples could cause false positive results on a FTS. Methods:20 ng/mL Rapid Response immunoassay Fentanyl Test Strips (FTS) were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants (cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)) in concentrations from 20 mg/mL to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection. Results: False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants. Conclusions:Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drug adulterants are in high concentrations, FTS can give a false positive result.
- 16 October 2020
- Published by Springer Nature in Research Square
Open AccessHigh Concentrations of Illicit Stimulants and Cutting Agents Cause False Positives on Fentanyl Test Strips
Background:The opioid epidemic has caused an increase of overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interference. We tested whether these concentrated samples could cause false positive results on a FTS. Methods:20 ng/mL Rapid Response immunoassay Fentanyl Test Strips (FTS) were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants (cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)) in concentrations from 20 mg/mL to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection. Results: False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants. Conclusions:Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drug adulterants are in high concentrations, FTS can give a false positive result.
- 30 March 2020
- Published by Wiley in Journal of Forensic Sciences
- Vol. 65 (4) , 1289-1297
idPAD: Paper Analytical Device for Presumptive Identification of Illicit Drugs
As drug overdose deaths across the United States continue to rise, there is increasing interest in field testing of illicit substances. This work discusses a paper‐based analytical device (idPAD) that can run a library of 12 colorimetric tests at the same time, each detecting different chemical functional groups and materials found in illicit drugs, distractor substances, and cutting agents. The idPAD requires no electricity, costs less than $2 USD, and requires minimal training to operate. The results of the 12 tests form a color barcode which is “read” by comparison to standard images. The accuracy of the idPAD was assessed using samples of heroin, cocaine HCl, crack, and methamphetamine at concentrations of 25%–100% in a lactose matrix, as well as pure lactose. Based on 840 “reads” by three different users, the idPAD showed 95% sensitivity and 100% specificity for detecting these drugs; the most common error was mistaking cocaine HCl for crack or crack for cocaine HCl. In a second step, samples of heroin, cocaine, and methamphetamine (n = 30) and distractor substances (pharmaceuticals, cutting agents, and other illicit drugs, n = 64) were tested by two readers, yielding a sensitivity of 100% and specificity of 97%. Targeted substances were detected reliably at 55–180 μg/lane, and the idPAD was found to be stable for at least 3 months when stored at room temperature. The library approach used in the idPAD may provide the accuracy and robustness necessary for a presumptive field drug test.
- 30 March 2020
- Published by Wiley in Journal of Forensic Sciences
- Vol. 65 (4) , 1289-1297
idPAD: Paper Analytical Device for Presumptive Identification of Illicit Drugs
As drug overdose deaths across the United States continue to rise, there is increasing interest in field testing of illicit substances. This work discusses a paper‐based analytical device (idPAD) that can run a library of 12 colorimetric tests at the same time, each detecting different chemical functional groups and materials found in illicit drugs, distractor substances, and cutting agents. The idPAD requires no electricity, costs less than $2 USD, and requires minimal training to operate. The results of the 12 tests form a color barcode which is “read” by comparison to standard images. The accuracy of the idPAD was assessed using samples of heroin, cocaine HCl, crack, and methamphetamine at concentrations of 25%–100% in a lactose matrix, as well as pure lactose. Based on 840 “reads” by three different users, the idPAD showed 95% sensitivity and 100% specificity for detecting these drugs; the most common error was mistaking cocaine HCl for crack or crack for cocaine HCl. In a second step, samples of heroin, cocaine, and methamphetamine (n = 30) and distractor substances (pharmaceuticals, cutting agents, and other illicit drugs, n = 64) were tested by two readers, yielding a sensitivity of 100% and specificity of 97%. Targeted substances were detected reliably at 55–180 μg/lane, and the idPAD was found to be stable for at least 3 months when stored at room temperature. The library approach used in the idPAD may provide the accuracy and robustness necessary for a presumptive field drug test.
- 4 February 2020
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 12 (8) , 1077-1084
Enzyme-based paper test for detection of lactose in illicit drugs
Lactose is commonly used as a cutting agent in illicit drugs. Currently, presumptive field color test kits for illicit drugs do not test for the presence of lactose or other cutting agents. A method was developed to detect lactose on a paper-based test card. A three-enzyme system comprised of lactase, glucose oxidase, and peroxidase was used to break down lactose into peroxide, which was then detected with a redox indicator. The test can detect lactose concentrations as low as 5% in solid samples and shows no interference when lactose is mixed with illicit drugs or commercial pharmaceuticals. Prepared test cards were stable on the shelf for up to five months. In a blinded study of samples composed of mixtures of heroin, methamphetamine, cocaine HCl, crack cocaine, fillers, and lactose, the sensitivity for detection of lactose across three readers was 100% and specificity was 96.4% (n = 96). When this test was incorporated into a 12-lane test card for the detection of illicit drugs, readers were correctly able to identify the illicit drug and the presence of lactose with 99.3% sensitivity and 100% specificity (n = 54). This test is a robust and affordable way to detect lactose in illicit drug samples.
- 4 February 2020
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 12 (8) , 1077-1084
Enzyme-based paper test for detection of lactose in illicit drugs
Lactose is commonly used as a cutting agent in illicit drugs. Currently, presumptive field color test kits for illicit drugs do not test for the presence of lactose or other cutting agents. A method was developed to detect lactose on a paper-based test card. A three-enzyme system comprised of lactase, glucose oxidase, and peroxidase was used to break down lactose into peroxide, which was then detected with a redox indicator. The test can detect lactose concentrations as low as 5% in solid samples and shows no interference when lactose is mixed with illicit drugs or commercial pharmaceuticals. Prepared test cards were stable on the shelf for up to five months. In a blinded study of samples composed of mixtures of heroin, methamphetamine, cocaine HCl, crack cocaine, fillers, and lactose, the sensitivity for detection of lactose across three readers was 100% and specificity was 96.4% (n = 96). When this test was incorporated into a 12-lane test card for the detection of illicit drugs, readers were correctly able to identify the illicit drug and the presence of lactose with 99.3% sensitivity and 100% specificity (n = 54). This test is a robust and affordable way to detect lactose in illicit drug samples.
- 17 September 2018
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 10 (38) , 4718-4722
Identification of substandard and falsified antimalarial pharmaceuticals chloroquine, doxycycline, and primaquine using surface-enhanced Raman scattering
Falsified antimalarial pharmaceuticals are a worldwide problem with negative public health implications.
- 17 September 2018
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 10 (38) , 4718-4722
Identification of substandard and falsified antimalarial pharmaceuticals chloroquine, doxycycline, and primaquine using surface-enhanced Raman scattering
Falsified antimalarial pharmaceuticals are a worldwide problem with negative public health implications.